Current
$166B
5-Year Average
$111B
All-Time High
$195B
All-Time Low
$5.15B
Market cap daily chart for Gilead Sciences (GILD)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for Gilead Sciences (GILD) from 2017 to 2026
Latest: +8.1%
Market Cap history table for Gilead Sciences (GILD) from 1992 to 2026
| 2026 | $166B | +8.1% | +$12.4B | ||
| 2025 | $154B | +32.9% | +$38.1B | ||
| 2024 | $116B | +13.8% | +$14B | ||
| 2023 | $102B | -5.9% | -$6.43B | ||
| 2022 | $108B | +18.2% | +$16.7B | ||
| 2021 | $91.6B | +24.5% | +$18.1B | ||
| 2020 | $73.6B | -11.3% | -$9.4B | ||
| 2019 | $83B | +1.4% | +$1.16B | ||
| 2018 | $81.8B | -13.4% | -$12.7B | ||
| 2017 | $94.5B | -2.8% | -$2.75B | ||
| 2016 | $97.2B | -36.8% | -$56.7B | ||
| 2015 | $154B | -0.9% | -$1.34B | ||
| 2014 | $155B | +22.0% | +$28B | ||
| 2013 | $127B | +119.0% | +$69.1B | ||
| 2012 | $58.1B | +79.8% | +$25.8B | ||
| 2011 | $32.3B | +2.1% | +$680M | ||
| 2010 | $31.7B | -21.7% | -$8.78B | ||
| 2009 | $40.4B | -17.6% | -$8.61B | ||
| 2008 | $49B | +10.5% | +$4.67B | ||
| 2007 | $44.4B | +48.8% | +$14.6B | ||
| 2006 | $29.8B | +19.6% | +$4.88B | ||
| 2005 | $24.9B | +53.4% | +$8.68B | ||
| 2004 | $16.2B | +38.5% | +$4.52B | ||
| 2003 | $11.7B | +67.1% | +$4.71B | ||
| 2002 | $7.02B | +5.5% | +$368M | ||
| 2001 | $6.65B | +76.3% | +$2.88B | ||
| 2000 | $3.77B | +62.9% | +$1.46B | ||
| 1999 | $2.32B | +37.9% | +$636M | ||
| 1998 | $1.68B | +34.6% | +$432M | ||
| 1997 | $1.25B | +79.7% | +$553M | ||
| 1996 | $695M | +2.0% | +$13.9M | ||
| 1995 | $681M | +284.8% | +$504M | ||
| 1994 | $177M | — | — | ||
| 1992 | $308M | — | — |
- 2026$166B+8.1%
- 2025$154B+32.9%
- 2024$116B+13.8%
- 2023$102B-5.9%
- 2022$108B+18.2%
- 2021$91.6B+24.5%
- 2020$73.6B-11.3%
- 2019$83B+1.4%
- 2018$81.8B-13.4%
- 2017$94.5B-2.8%
- 2016$97.2B-36.8%
- 2015$154B-0.9%
- 2014$155B+22.0%
- 2013$127B+119.0%
- 2012$58.1B+79.8%
- 2011$32.3B+2.1%
- 2010$31.7B-21.7%
- 2009$40.4B-17.6%
- 2008$49B+10.5%
- 2007$44.4B+48.8%
- 2006$29.8B+19.6%
- 2005$24.9B+53.4%
- 2004$16.2B+38.5%
- 2003$11.7B+67.1%
- 2002$7.02B+5.5%
- 2001$6.65B+76.3%
- 2000$3.77B+62.9%
- 1999$2.32B+37.9%
- 1998$1.68B+34.6%
- 1997$1.25B+79.7%
- 1996$695M+2.0%
- 1995$681M+284.8%
- 1994$177M—
- 1992$308M—
Market Cap values are taken from Gilead Sciences's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's latest reported market cap is $175B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for Gilead Sciences (GILD) came in at $166B – grew 8.1% year-over-year.
Gilead Sciences market cap compound annual growth for the 2021–2026 (5 years) window is +12.7%, sustaining 3 straight years of year-over-year growth.
The record annual market cap stands at $166B, reached in 2026; the historical low of $177M was recorded in 1994.
Gilead Sciences Market Cap by Year
Gilead Sciences Market Cap 2026: $166B
Gilead Sciences market cap in 2026 was $166B, grew 8.1% from 2025. This figure represents the highest annual value in the available history.
Gilead Sciences Market Cap 2025: $154B
2025's market cap for Gilead Sciences came in at $154B, surged 32.9% from 2024.
Gilead Sciences Market Cap 2024: $116B
Gilead Sciences posted market cap of $116B in 2024, grew 13.8% from 2023.
Gilead Sciences Market Cap 2023: $102B
In 2023, Gilead Sciences reported market cap of $102B, declined 5.9% below 2022.
Gilead Sciences Market Cap 2022: $108B
Gilead Sciences market cap in 2022 was $108B.
See more financial history for Gilead Sciences (GILD).
Sector peers by Market Cap
Healthcare peers of Gilead Sciences (GILD), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $466B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B |
- $1.14T
- $466B
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on GILD
Market Cap — 10 rounds, every one of them GILD against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.93% TTM
- Dividend Profile2.43% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.